Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BM.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5 (Omicron)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2 (Omicron)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.66EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
BA.5.2.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.3.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GE.1.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.58.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.8.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDD.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDNEWon-ECACACAATCGATGCGCAGTA20502636526346R-2361.24South Korea
HW.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.55.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.18.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDK.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1 (Omicron)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4 (Omicron)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used